Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To report outcomes of pregnancies that occurred during the fingolimod clinical development program.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Neurology

Title: Neurology

ISSN (Electronic): 1526-632X

ISSN (Print): 0028-3878

Publication date (Electronic): Feb 25 2014

Volume: 82

Issue: 8

Affiliations

[1 ] From Novartis Pharma AG (G. Karlsson, P.H., W.C.), Basel, Switzerland; Novartis Pharmaceuticals Corporation (G.F., X.Z.), East Hanover, NJ; Motherisk Program (G. Koren), Hospital for Sick Children, Toronto, Canada; Neurological Institute (J.A.C.), Cleveland Clinic, OH; and Neurology and Department of Biomedicine (L.K.), University Hospital, Basel, Switzerland.

Article

Publisher Item ID: WNL.0000000000000137

DOI: 10.1212/WNL.0000000000000137

PubMed ID: 24463630

SO-VID: 0a55f4af-45f3-49c8-ba12-232d56d6b8e4

History

Data availability:

Comments

Comment on this article

scite_

Cited by 40

See all cited by